Remove company careers
article thumbnail

Woman of the Week: Foresite Capital’s Cindy Mesaros

PharmaVoice

The longtime marketing pro details her fascinating career journey and how she’s positioning early stage health companies to thrive.

246
246
article thumbnail

ELRIG UK and SRG collaborate to advance life sciences professionals in drug discovery

Pharma Times

Both companies will facilitate career progression while advancing the life sciences industry

108
108
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Calico looking for new chief scientist after celebrated biologist David Botstein quietly retires

STAT

Are you a promising middle or late-career scientist with a desire to extend human lifespan, experience leading a large organization, and a fondness for naked mole rats? The massively funded research and development company is without a chief scientific officer after the celebrated biologist David Botstein quietly retired last year.

242
242
article thumbnail

To detect breast cancer sooner, an MIT professor designs an ultrasound bra

STAT

Canan Dagdeviren has dedicated her career to creating tools that can capture data from every nook and cranny of the human body. On Friday, Dagdeviren and her colleagues at the Massachusetts Institute of Technology published new research on the ultrasound device that will form the basis of a company. Read the rest…

246
246
article thumbnail

STAT+: Vir CEO George Scangos to retire, after pandemic success

STAT

Vir Biotechnology CEO George Scangos said on Wednesday he will retire, ending an itinerant, nearly 40-year-career as one of biotech’s most recognizable executives. Scangos, 74, will be succeeded in April by Marianne De Backer , a longtime pharma executive who currently heads pharmaceutical strategy at Bayer.

244
244
article thumbnail

Veeda Board appoints Dr Mahesh Bhalgat as Group CEO

Express Pharma

Prior to joining Veeda, he was the COO for Syngene International (Biocon Group Company). He started his India career with Biological E, which he joined after 20 years in North America pursuing his study and working with multi-national drug development companies, which include Amgen and Monsanto and Thermofisher.

article thumbnail

Opinion: Can Arena Bioworks upend the traditional scientific research model in the U.S.?

STAT

I’ve spent a good deal of my career thinking about how we structure and fund research in the biomedical sciences in the U.S. and questioning whether the U.S. model of embedding research in universities is the right one. So to me, the launch of Arena BioWorks is welcome news.

236
236